Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine effects on interoception, pain threshold, and somatic symptoms in major depression
2006-001079-39Phase 4Active
- Sponsor
- Universitätsklinikum Bonn
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of duloxetine in major depressive disorder (MDD), sponsored by Universitätsklinikum Bonn. Primary endpoints: Change in activation of the interoceptive system during heartbeat detection and Change in activation during pain-threshold determination. Started Mar 2006; status: active.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2006-001079-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001079-39.